About Centre Paradis Monticelli
Clinical Trials at Centre Paradis Monticelli
During the past decade, Centre Paradis Monticelli conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 5 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre Paradis Monticelli" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Apellis Pharmaceuticals, Inc." with 2 trials
sponsored, "Bayer" with 2 trials sponsored, "Gyroscope Therapeutics Limited" with 2 trials sponsored and "Kodiak Sciences Inc"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Paradis Monticelli"
#1 collaborator was "Novartis Pharmaceuticals" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Molecular Partners AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Centre Paradis Monticelli
According to Clinical.Site data, the most researched conditions in "Centre Paradis Monticelli" are
"Geographic Atrophy" (7 trials), "Diabetic Macular Edema" (4 trials), "Dry Age-related Macular Degeneration" (2 trials), "Macular Degeneration" (2 trials) and "Retinal Vein Occlusion" (2 trials). Many other conditions were trialed in "Centre Paradis Monticelli" in a lesser frequency.
Clinical Trials Intervention Types at Centre Paradis Monticelli
Most popular intervention types in "Centre Paradis Monticelli" are "Drug" (15 trials), "Other" (8 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Faricimab" (3 trials), "KSI-301" (2 trials) and "No intervention" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Paradis Monticelli
The vast majority of trials in "Centre Paradis Monticelli" are
21 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Centre Paradis Monticelli
Currently, there are NaN active trials in "Centre Paradis Monticelli".
1 are not yet recruiting,
2 are recruiting,
10 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Centre Paradis Monticelli,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Paradis Monticelli, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".